2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and processes for their preparation

Information

  • Patent Grant
  • 9988365
  • Patent Number
    9,988,365
  • Date Filed
    Thursday, March 19, 2015
    9 years ago
  • Date Issued
    Tuesday, June 5, 2018
    6 years ago
Abstract
Provided herein are 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and 1-(2,4-difluorophenyl)-2,2-difluoro-2-(5-substituted-pyridin-2-yl)ethanones and processes for their preparation.
Description
FIELD

Provided herein are 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and processes for their preparation. In another embodiment provided herein are 1-(2,4-difluorophenyl)-2,2-difluoro-2-(5-substituted-pyridin-2-yl)ethanones and processes for their preparation.


BACKGROUND

U.S. patent application Ser. Nos. 13/527,387, 13/527,426 and 13/528,283 describe inter alia certain metalloenzyme inhibitor compounds and their use as fungicides. The disclosure of each application is expressly incorporated by reference herein. Each of these patents describes the various routes to generate metalloenzyme inhibiting fungicides. It may be advantageous to provide more direct and efficient methods for the preparation of metalloenzyme inhibiting fungicides and related compounds, e.g., by the use of reagents and/or chemical intermediates which provide improved time and cost efficiency.


SUMMARY OF THE DISCLOSURE

Provided herein are 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and 1-(2,4-difluorophenyl)-2,2-difluoro-2-(5-substituted-pyridin-2-yl)ethanones and processes for their preparation. In one embodiment, provided herein is a process for the preparation of a compound of the Formula VI:




embedded image



wherein R1 is selected from:




embedded image



and Br,


which comprises contacting compounds of Formula V with triethyl orthoformate and sodium azide in the presence of acetic acid.




embedded image


In another embodiment, compounds of Formula V may be prepared by contacting compounds of Formula IV with a metal and an acid selected from acetic acid and hydrochloric acid.




embedded image


In another embodiment, compounds of Formula IV may be prepared by contacting compounds of Formula III with nitromethane and a base.




embedded image


In another embodiment, compounds of Formula III may be prepared by contacting compounds of Formula II with a preformed organometallic reagent.




embedded image


In another embodiment, compounds of Formula III may be prepared by contacting compounds of Formula IIa with a preformed organometallic reagent.




embedded image


In another embodiment, compounds of Formula IIa may be prepared by contacting compounds of Formula II with an amine, a Lewis acid, and a solvent.




embedded image


In another embodiment, compounds of Formula II may be prepared by contacting compounds of the Formula I with ethyl 2-bromo-2,2-difluoroacetate and a metal.




embedded image


The term “cyano” refers to a —C≡N substituent.


The term “hydroxyl” refers to an —OH substituent.


The term “amino” refers to a —NH2 substituent.


The term “alkylamino” refers to a —N(H)—R substituent.


The term “dialkylamino” refers to a —NR2 substituent.


The term “halogen” or “halo” refers to one or more halogen atoms, defined as F, Cl, Br, and I.


The term “nitro” refers to a —NO2 substituent.


The term “Lewis acid” refers to any substance that is an electron pair acceptor.


The term “organometallic” refers to an organic compound containing a metal, especially a compound in which a metal atom is bonded directly to a carbon atom.


Throughout the disclosure, references to the compounds of Formula VII, VI, V, and IV are read as also including optical isomers and salts. Specifically, when compounds of Formula VII, VI, V, or IV contain a branched chain alkyl group, it is understood that such compounds include optical isomers and racemates thereof. Exemplary salts may include: hydrochloride, hydrobromide, hydroiodide, and the like. Additionally, the compounds of Formula VII, VI, V, and IV may include tautomeric forms.


Certain compounds disclosed in this document can exist as one or more isomers. It will be appreciated by those skilled in the art that one isomer may be more active than the others. The structures disclosed in the present disclosure are drawn in only one geometric form for clarity, but are intended to represent all geometric and tautomeric forms of the molecule.


The embodiments described above are intended merely to be exemplary, and those skilled in the art will recognize, or will be able to ascertain using no more than routine experimentation, numerous equivalents of specific compounds, materials, and procedures. All such equivalents are considered to be within the scope of the invention and are encompassed by the appended claims.







DETAILED DESCRIPTION

2-(2,4-Difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and 1-(2,4-difluorophenyl)-2,2-difluoro-2-(5-substituted-pyridin-2-yl)ethanones provided herein may be prepared from 6-bromopyridin-3-ol as shown in Examples 1-8.


Example 1: Preparation of 4-((6-bromopyridin-3-yl)oxy)benzonitrile (1)



embedded image



Method A:


To a stirred solution of 6-bromopyridin-3-ol (5.0 g, 28.7 mmol) and 4-fluorobenzonitrile (3.48 g, 28.7 mmol) in dry DMSO (57.5 mL) under nitrogen was added cesium carbonate (14.04 g, 43.1 mmol). The reaction mixture was stirred at 75° C. for 18 h. The reaction was poured into ice water. The pH was adjusted to make the solution mildly acidic (pH=6) using 1 N HCl. The resulting precipitate was filtered and washed with water followed by a minimum amount of ether to give the title compound as a brown solid (6.292 g, 76%).


Method B:


To a stirred solution of 6-bromopyridin-3-ol (17.3 g, 100 mmol) and 4-fluorobenzonitrile (12.1 g, 120 mmol) in DMF (150 mL) under nitrogen was added Cs2CO3 (32.5 g, 120 mmol). The reaction mixture was stirred at 85-90° C. for 10-15 h. HPLC indicated the reaction was complete. Into the reaction mixture cooled to 10-15° C. (ice bath) was charged water (450 mL) to precipitate the product. The resulting precipitate was filtered, washed with acetonitrile-water (1:4) and water, and dried in a vacuum oven to give the title compound as a white solid (25 g, 91%). The product was slurried in EtOH (50 mL) at room temperature for 2-3 h to remove the side product. The suspension was filtered to collect the title compound as a white solid (23.5 g, 85%).


This reaction was also carried out as described in Example 1, Method A with the exception that potassium carbonate was used in place of cesium carbonate.


The following compounds 1-3 in Table 1a were made in accordance with the reaction depicted in Scheme 1 and the procedures described in Example 1. Characterization data for compounds 1-3 are shown in Table 1b.




embedded image













TABLE 1a








Prepared as



Compound


in



No.
R1
Appearance
Example(s):
R2—F







1


embedded image


Brown solid
Ex 1, Methods A and B


embedded image







2


embedded image


Off-white solid
Ex 1, Method B


embedded image







3


embedded image


White Solid
Ex 1, Method B


embedded image























TABLE 1b





Compound
Mp
ESIMS


13C NMR or

IR(thin


No.
(° C.)
m/z

1H NMR (δ)a


19F NMR (δ)

film) cm−1



















1
113
275
8.22 (d, J = 2.9 Hz,





([M]+)
1H), 7.70-7.63 (m,





2H), 7.56-7.51 (m,





1H), 7.28 (dd, J = 8.5,





2.9 Hz, 1H), 7.10-





7.02 (m, 2H)


2


8.39-8.32 (m, 1H),

13C NMR (101






8.27-8.22 (m, 1H),
MHz, CDCl3) δ





7.97-7.85 (m, 1H),
164.46 (s), 149.27





7.49 (dd, J = 8.6, 0.5
(s), 145.02 (q, J =





Hz, 1H), 7.41 (dd, J =
4.3 Hz), 143.88





8.6, 2.9 Hz, 1H), 7.09
(s), 139.03-





(d, J = 8.7 Hz, 1H)
134.92 (m),






132.18 (s), 128.54






(s), 124.81 (s),






122.54 (q, J =






33.3 Hz), 122.12






(s), 111.83 (s)


3

284
8.27 (dd, J = 3.0, 0.6




([M]+)
Hz, 1H), 8.08 (dd, J =





2.7, 0.7 Hz, 1H), 7.71





(dd, J = 8.7, 2.6 Hz,





1H), 7.51 (dd, J = 8.6,





0.6 Hz, 1H), 7.41 (dd,





J = 8.6, 2.9 Hz, 1H),





6.98 (dd, J = 8.7, 0.7





Hz, 1H)






aAll 1H NMR data measured in CDCl3 at 400 MHz unless otherwise noted







Example 2. Preparation of 2-bromo-5-(2,2,2-trifluoroethoxy)pyridine



embedded image


6-Bromopyridin-3-ol (32.5 g, 187 mmol) and cesium carbonate (70.6 g, 217 mmol) were placed into a 1 L, 3-neck Morton flask equipped with a temperature probe, an overhead stirrer, and an addition funnel topped with a nitrogen line. A 9° C. cooling bath was applied before the solids were charged with DMF (325 mL). The temperature increased from 15° C. to 20° C. when 2,2,2-trifluoroethyl trifluoromethanesulfonate (30.8 mL, 50.6 g, 212 mmol) was added by syringe over 27 min to the heterogeneous mixture of other components. The purple solution was stirred for 1 h 40 min before re-cooling with a 10° C. water bath. The solution was cooled to room temperature after the addition of water (650 mL). The mixture was extracted five times with 200 mL portions of 3:1 hexane-ethyl acetate. The combined organic layers were washed three times with 150 mL portions of water, dried over Na2SO4, filtered, and concentrated. The oil was then concentrated twice from 100 mL portions of hexane to give the title compound as a white solid (47.21 g, 99%): 1H NMR (400 MHz, CDCl3) δ 8.12 (d, J=3.2 Hz, 1H), 7.44 (dd, J=8.8, 0.6 Hz, 1H), 7.19 (dd, J=8.7, 3.2 Hz, 1H), 4.40 (q, J=7.9 Hz, 2H); 19F NMR −73.87; ESIMS m/z 256 ([M+H]+).


Example 3: Preparation of ethyl 2-(5-(4-cyanophenoxy)pyridin-2-yl)-2,2-difluoroacetate (5)



embedded image



Method A:


Crude 4-((6-bromopyridin-3-yl)oxy)benzonitrile was dried azeotropically with toluene to remove any possible trace water from the starting material. A magnetically stirred mixture of ethyl 2-bromo-2,2-difluoroacetate (3.08 mL, 23.99 mmol) and copper (2.98 g, 46.9 mmol) in dry DMSO (33.7 mL) was stirred at rt for 1 h, then 4-((6-bromopyridin-3-yl)oxy)benzonitrile (5.57 g, 20.25 mmol) was added in one portion. The reaction mixture was stirred at 60° C. for 3 days. The reaction was determined to be complete by TLC. The heat source was removed and the reaction diluted with EtOAc (100 mL) and stirred for 20 minutes. The reaction was filtered through a plug of celite and washed with EtOAc. The filtrate was washed with saturated NH4Cl (3×) to remove any remaining copper. The solution was dried, and the solvent was removed under reduced pressure to produce crude product as a brown oil (5.947 g, 83%). The residue was purified by silica gel chromatography (0-20% EtOAc/hexanes) to give the title compound as a clear oil (two lots: (3.897 g, 59.9%, 99% purity) and (804 mg, 11.23%, 90% purity).


Method B:


A magnetically stirred mixture of 4-((6-bromopyridin-3-yl)oxy)benzonitrile (27.5 g, 20 mmol), ethyl 2-bromo-2,2-difluoroacetate (4.47 g, 22 mmol), copper (2.67 g, 42 mmol) and methanesulfonic acid (38 mg, 0.4 mmol) in dry DMF (50 mL) was stirred at 40-45° C. The reaction was complete by HPLC. The reaction mixture was cooled to room temperature, then diluted with toluene (200 mL) and stirred for 0.5 h at room temperature before filtration through celite and washing with additional toluene. The filtrate was washed with 20% NH4Cl (50 mL) and water (25 mL×2). The organic layer was concentrated with additional acetonitrile under reduced pressure to remove water. The solution was concentrated and dried under in vacuo to give the title compound as a brown oil (5.3 g, 83%).


The following compounds 5-10 in Table 3a were made in accordance with the reaction depicted in Scheme 3 and the procedures described in Example 3. Characterization data for compounds 5-10 are shown in Table 3b.




embedded image












TABLE 3a





Compound


Prepared as in


No.
R1
Appearance
Example(s):


















5


embedded image


Brown oil
Ex 3, Methods A and B





6


embedded image


Amber oil
Ex 3, Method B





7


embedded image


Colorless oil
Ex 3, Method B





8


embedded image


Brown oil
Ex 3, Method B





9
Br
Clear
Ex 3,




Colorless oil
Method A





10


embedded image


Yellow oil
Ex 3, Method B





















TABLE 3b





Compound
Mp
ESIMS


13C NMR or

IR(thin


No.
(° C.)
m/z

1H NMR (δ)a


19F NMR (δ)

film) cm−1




















5

319
(300 MHz, CDCl3) δ

2229,




([M + H]+)
8.44 (d, J = 2.7 Hz,

1767





1H), 7.78 (d, J = 8.7





Hz, 1H), 7.73-7.64





(m, 2H), 7.49 (dd, J =





8.6, 2.7 Hz, 1H), 7.16-





7.07 (m, 2H), 4.39





(q, J = 7.1 Hz, 2H),





1.35 (t, J = 7.2 Hz,





3H)


6

300
8.37 (dd, J = 2.9, 0.6

19F NMR −73.82





([M + H]+)
Hz, 1H), 7.72 (dd, J =
(s, 3F), −104.24





8.8, 0.7 Hz, 1H), 7.39
(s, 2F)





(dd, J = 8.7, 2.9 Hz,





1H), 4.46 (q, J = 7.9





Hz, 2H), 4.37 (q, J =





7.1 Hz, 2H), 1.33 (t,





J = 7.1 Hz, 3H)


7

363
8.54 (d, J = 2.5 Hz,




([M + H]+)
1H), 8.48-8.37 (m,





1H), 8.06-7.93 (m,





1H), 7.82 (dd, J = 8.6,





0.6 Hz, 1H), 7.72 (dd,





J = 8.6, 2.6 Hz, 1H),





7.16 (d, J = 8.7 Hz,





1H), 4.40 (q, J = 7.1





Hz, 2H), 1.36 (t, J =





7.1 Hz, 3H)


8

328
8.51 (dd, J = 2.7, 0.7




([M]+)
Hz, 1H), 8.10 (dd, J =





2.7, 0.7 Hz, 1H), 7.78





(dd, J = 8.7, 0.7 Hz,





1H), 7.67 (dd, J = 8.6,





2.6 Hz, 1H), 7.01 (dd,





J = 8.7, 0.7 Hz, 1H),





4.39 (q, J = 7.1 Hz,





2H), 1.35 (t, J = 7.1





Hz, 3H)


9

281

1H NMR (400 MHz,


19F NMR −105.2 (s)





([M + H]+)
CDCl3) δ 8.71 (dd, J =





2.23, 0.57 Hz, 1H),





8.00 (dd, J = 8.4, 2.3





Hz, 1H), 7.65 (dd, J =





8.4, 0.7 Hz, 1H), 4.37





(q, J = 7.1 Hz, 2H),





1.33 (t, J = 7.1 Hz,





3H)


10


8.59 (s, 1H), 7.85 (dd,

2990,





J = 8.2, 1.4 Hz, 1H),

1768





7.76 (d, J = 8.1 Hz,





1H), 4.38 (q, J = 7.1





Hz, 2H), 3.48 (q, J =





10.5 Hz, 2H), 1.33 (t,





J = 7.1 Hz, 3H)






aAll 1H NMR data measured in CDCl3 at 400 MHz unless otherwise noted







Example 4: Preparation of 2-(5-(4-cyanophenoxy)pyridin-2-yl)-2,2-difluoro-N-methoxy-N-methylacetamide (11)



embedded image


To a 1 L three neck round bottom flask equipped with an overhead stirrer, a temperature probe, a nitrogen inlet, and an addition funnel and cooled in an ice-water bath was charged N,O-dimethylhydroxylamine hydrochloride (6.15 g, 63 mmol) and dichloromethane (63 mL). A solution of dimethylaluminum chloride (63 mL, 63 mmol, 1M solution in hexane) was added slowly to keep the temperature below 15° C. Upon the completion of addition, the ice-water bath was removed and the reaction allowed to warm to room temperature for 1 h. A solution of ethyl 2-(5-(4-cyanophenoxy)pyridin-2-yl)-2,2-difluoroacetate (13.37 g, 42 mmol) in CH2Cl2 (21 mL) was added over 5-10 min and the mixture was stirred at rt for 3-5 h and the reaction proceeded to completion as indicated by HPLC. The reaction was cooled to 5° C. and quenched by a slow addition of 10% potassium sodium tartrate solution (400 mL). After addition of potassium sodium tartrate, the reaction mixture was stirred at room temperature for 1 h. After separation of the organic layer, the aqueous layer was extracted with additional CH2Cl2. The combined organic layers were washed with 10% NaHCO3 and water. The organic layer was concentrated and replaced with heptane to solidify the product. The product was filtered, washed with heptane and dried overnight in vacuo to give the title compound as a light yellow solid (12 g, 86%).


The following compounds 11-18 in Table 4a were made in accordance with the reaction depicted in Scheme 4 and the procedures described in Example 4. Characterization data for compounds 11-18 are shown in Table 4b.




embedded image













TABLE 4a





Com-



Prepared as


pound



in


No.
R1
—N(R3)(R4)
Appearance
Example(s):







11


embedded image


—N(OCH3)(CH3)
Light yellow solid
Ex 4





12


embedded image


—N(CH3)(CH3)
Oil
Ex 4





13


embedded image


—N(CH2CH3)(CH2CH3)
Oil
Ex 4





14


embedded image




embedded image


Clear oil
Ex 4





15


embedded image


—N(OCH3)(CH3)
Off-white solid
Ex 4





16


embedded image


—N(OCH3)(CH3)
Light yellow solid
Ex 4





17


embedded image


—N(OCH3)(CH3)
Yellow solid
Ex 4





18


embedded image


—N(OCH3)(CH3)
Oil
Ex 4





















TABLE 4b





Compound
Mp
ESIMS


13C NMR or

IR(thin


No.
(° C.)
m/z

1H NMR (δ)a


19F NMR (δ)

film) cm−1



















11
101
334
8.42 (d, J = 4.0 Hz, 1H),






7.71 (m, 3H), 7.49 (dd, J =





8.0, 4.0 Hz, 1H), 7.10





(m, 2H), 3.56 (s, 3H), 3.29





(s, 3H)


12

319
8.45 (dd, J = 2.8, 0.7 Hz,

19F NMR (376






1H), 7.81-7.63 (m, 3H),
MHz, CDCl3)





7.50 (dd, J = 8.6, 2.8 Hz,
δ −97.58 (s)





1H), 7.18-7.05 (m, 2H),





3.15 (t, J = 1.9 Hz, 3H),





3.07 (t, J = 0.8 Hz, 3H)


13

346
8.45 (d, J = 4.0 Hz, 1H),
162.28, 159.65,





7.72 (m, 3H), 7.49 (dd, J =
153.10, 148.85,





12.0, 4.0 Hz, 1H), 7.10
141.36, 134.53,





(m, 2H), 3.47 (m, 4H),
127.39, 122.22,





1.20 (m, 6H)
118.95, 118.23,






114.24, 107.89,






42.24, 41.73,






14.16, 12.27


14

359
(300 MHz, CDCl3) δ 8.44





(d, J = 2.7 Hz, 1H), 7.76





(d, J = 8.6 Hz, 1H), 7.69





(m, 2H), 7.49 (dd, J = 8.7,





2.7 Hz, 1H), 7.11 (m, 2H),





3.70 (m, 8H)


15

315
8.34 (d, J = 2.9 Hz, 1H),

19F NMR −73.79





([M + H]+)
7.68 (d, J = 8.8 Hz, 1H),
(s, 3F), −100.76





7.41 (dd, J = 8.7, 2.9 Hz,
(s, 2F)





1H), 4.46 (q, J = 7.9 Hz,





2H), 3.49 (s, 3H), 3.27 (s,





3H)


16

378
8.52 (d, J = 2.4 Hz, 1H),




([M + H]+)
8.46-8.38 (m, 1H), 8.03-7.94





(m, 1H), 7.78 (dd, J =





8.6, 0.4 Hz, 1H), 7.72





(dd, J = 8.6, 2.5 Hz, 1H),





7.15 (d, J = 8.6 Hz, 1H),





3.50 (s, 3H), 3.29 (s, 3H)


17

343
8.49 (dd, J = 2.6, 0.8 Hz,




([M]+)
1H), 8.10 (dd, J = 2.6, 0.7





Hz, 1H), 7.78-7.70 (m,





2H), 7.67 (dd, J = 8.6, 2.6





Hz, 1H), 7.00 (dd, J = 8.7,





0.7 Hz, 1H), 3.50 (s, 3H),





3.29 (s, 3H)


18

299
8.56 (s, 1H), 7.83 (dd, J =




([M + H]+)
8.1, 1.6 Hz, 1H), 7.71 (d,





J = 7.9 Hz, 1H), 3.46





(m, 5H), 3.28 (s, 3H)






aAll 1H NMR data measured in CDCl3 at 400 MHz unless otherwise noted







Example 5: Preparation of 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-oxoethyl)pyridin-3-yl)oxy)benzonitrile (19)



embedded image


To a magnetically stirred mixture of magnesium (2.43 g, 100 mmol) in THF (50 mL) under N2 atmosphere was added a part of solution of 1-bromo-2,4-difluorobenzene (19.30 g, 11.3 mL, 100 mmol) in THF (25 mL) at 45° C. The solution was stirred for 0.5 h at 50-55° C. and cooled to 30° C. The rest of solution was charged slowly over 1 h at 30-40° C., and then the mixture was stirred for additional 1-2 h at room temperature.


Into the solution of 2-(5-(4-cyanophenoxy)pyridin-2-yl)-2,2-difluoro-N-methoxy-N-methylacetamide (16.6 g, 50 mmol) in THF (75 mL) at 0° C. was added the above freshly prepared Grignard solution slowly, and then the mixture was stirred for 0.5 h. After completion of reaction by HPLC, the reaction mixture was cooled to 5° C. (ice-water bath), followed by addition of 6N HCl (10 mL) and 20% NH4Cl (200 mL). The product was extracted with CH2Cl2 (400 mL). The organic layer was washed with additional 20% NH4Cl, 10% K2CO3 and water. The separated organic layer was concentrated and replaced with EtOH to give the title compound (19.3 g, 100%) that was used in the next step without further purification.


This reaction was also carried out as described in Example 5 with the exception of generating the arylmagnesium bromide reagent by reaction of the aryl bromide with isopropylmagnesium chloride.


The following compounds 19-23 in Table 5a were made in accordance with the reaction depicted in Scheme 5 and the procedures described in Example 5. Characterization data for compounds 19-23 are shown in Table 5b.




embedded image












TABLE 5a





Compound


Prepared as in


No.
R1
Appearance
Example(s):







19


embedded image


Yellow solid
Ex 5





20


embedded image


Amber solid
Ex 5





21


embedded image


Brown oil
Ex 5





22


embedded image


Brown Oil
Ex 5





23


embedded image


Yellow oil
Ex 5





















TABLE 5b





Compound
Mp
ESIMS


13C NMR or

IR(thin


No.
(° C.)
m/z

1H NMR (δ)a


19F NMR (δ)

film) cm−1



















19

387
(300 MHz, CDCl3) δ

19F NMR (376





([M + H]+)
8.36 (d, J = 2.7 Hz,
MHz, CDCl3)





1H), 8.15-8.02 (m,
δ −99.13 (d, J =





1H), 7.86 (d, J = 8.7
13.5 Hz), −100.67 (d,





Hz, 1H), 7.74-7.65
J = 14.9 Hz), −101.82





(m, 2H), 7.53 (dd, J =
(dd, J = 28.5, 14.2 Hz)





8.6, 2.7 Hz, 1H), 7.16-





7.06 (m, 2H), 7.05-6.96





(m, 1H), 6.84 (ddd,





J = 10.9, 8.6, 2.4 Hz, 1H)


20

368
8.29 (d, J = 2.8 Hz,




([M + H]+)
1H), 8.04 (td, J = 8.4,





6.4 Hz, 1H), 7.81 (d,





J = 8.6 Hz, 1H), 7.44





(dd, J = 8.7, 2.9 Hz,





1H), 6.99 (dddd, J =





8.7, 7.6, 2.4, 0.9 Hz,





1H), 6.82 (ddd, J =





11.0, 8.6, 2.4 Hz, 1H),





4.45 (q, J = 7.8 Hz,





2H)


21

431
8.53-8.37 (m, 1H),




([M + H]+)
8.09 (td, J = 8.4, 6.6





Hz, 1H), 8.05-7.97





(m, 1H), 7.90 (d, J =





8.5 Hz, 1H), 7.76 (dd,





J = 8.6, 2.6 Hz, 1H),





7.15 (d, J = 8.6 Hz,





1H), 7.05-6.90 (m,





1H), 6.84 (ddd, J =





11.0, 8.7, 2.4 Hz, 1H)


22

396
8.44 (dd, J = 2.6, 0.7




([M]+)
Hz, 1H), 8.12-8.03





(m, 2H), 7.86 (dd, J =





8.6, 0.7 Hz, 1H), 7.72





(ddd, J = 8.7, 4.4, 2.6





Hz, 2H), 7.04-6.96





(m, 2H), 6.84 (ddd, J =





11.0, 8.7, 2.4 Hz, 1H)


23

352
8.51 (s, 1H), 8.08 (m,




([M + H]+)
1H), 7.88 (dd, J = 8.2,





1.7 Hz, 1H), 7.84 (dd,





J = 8.1, 0.9 Hz, 1H),





7.00 (m, 1H), 6.83





(ddd, J = 10.8, 8.6, 2.4





Hz, 1H), 3.46 (q, J =





10.4 Hz, 2H)






aAll 1H NMR data measured in CDCl3 at 400 MHz unless otherwise noted







Example 6. Preparation of 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-oxoethyl)pyridin-3-yl)oxy)benzonitrile (19)



embedded image


To a magnetically stirred mixture of 1-bromo-2,4-difluorobenzene (0.923 mL, 8.17 mmol) in Et2O (21 mL) under N2 atmosphere at −78° C. was added slowly n-butyllithium (2.5 M in hexanes, 3.27 mL, 8.17 mmol). After completion of the addition, ethyl 2-(5-(4-cyanophenoxy)pyridin-2-yl)-2,2-difluoroacetate (2.00 g, 6.28 mmol) in Et2O (15 mL) was added, and the reaction was stirred at −60 to −50° C. for 1 h. The reaction was quenched with 2 N HCl until reaction mixture was acidic. The reaction was allowed to warm to room temperature, and the mixture then made basic with sat. aq. NaHCO3 solution. The layers were separated, and the aqueous layer was extracted with Et2O. The combined organic phases were dried (MgSO4) and concentrated. The crude product was dried on the rotavap under vacuum for 4 h to give the title compound as a yellow oil (2.515 g, 88%).


Compounds 19 and 25 in Table 6a were made in accordance with the reaction depicted in Scheme 6 and the procedures described in Example 6. Characterization data for compound 25 is shown in Table 6b.




embedded image












TABLE 6a





Compound


Prepared as in


No.
R1
Appearance
Example(s):







19


embedded image


Yellow solid
Ex 6





25
Br
White solid
Ex 6





















TABLE 6b





Compound
Mp
ESIMS


13C NMR or

IR(thin


No.
(° C.)
m/z

1H NMR (δ)a


19F NMR (δ)

film) cm−1


















25

349
8.67-8.58 (m, 1H),




([M + 1]+)
8.10-7.99 (m, 2H),





7.73 (dd, J = 8.4, 0.4





Hz, 1H), 7.05-6.94





(m, 1H), 6.83 (ddd, J =





10.7, 5.5, 1.4 Hz, 1H)






aAll 1H NMR data measured in CDCl3 at 400 MHz unless otherwise noted







Example 7. Preparation of 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-nitropropyl)pyridin-3-yl)oxy)benzonitrile (26)



embedded image



Method A:


To a magnetically stirred solution of 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-oxoethyl)pyridin-3-yl)oxy)benzonitrile (0.385 g, 0.897 mmol) in nitromethane (1.016 mL, 18.84 mmol) was added potassium carbonate (0.285 g, 2.063 mmol) under N2 atmosphere. The reaction mixture was stirred at 40° C. for 2 h. The reaction was quenched with acetic acid (2.0 mL) in water (15 mL). The mixture was extracted with Et2O, and the combined organic phases were washed with brine, sat. aq. NaHCO3, and water, dried (MgSO4) and concentrated to give the title compound as a yellow oil (427 mg, 99%).


Method B:


Into the mixture of 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-oxoethyl)pyridin-3-yl)oxy)benzonitrile (50 mmol) and K2CO3 (6.9 g, 50 mmol) in EtOH (150 mL, 190 proof) at rt was charged nitromethane (9.16 g, 150 mmol) and the suspension was stirred at rt. Into the reaction mixture cooled to −10° C. was added 20% NH4Cl (150 mL). The mixture was stirred until a solid formed, followed by adding additional 20% NH4Cl (300 mL). The suspension was stirred for 1-2 h at room temperature. The product was isolated through filtration and washed with water and dried in vacuo to give the title compound (19.3 g, 86%).


This reaction was also carried out as described in Example 7, Method A with the exception of potassium hydroxide being used in place of potassium carbonate and dimethylformamide being used as a solvent instead of neat nitromethane.


The following compounds 26-31 in Table 7a were made in accordance with the reaction depicted in Scheme 7 and the procedures described in Example 7. Characterization data for compounds 26-31 are shown in Table 7b.




embedded image












TABLE 7a





Compound


Prepared as in


No.
R1
Appearance
Example(s):







26


embedded image


White solid
Ex 7, Methods A and B





27


embedded image


Tan solid
Ex 7, Method B





28


embedded image


Vanilla color solid
Ex 7, Method B





29


embedded image


Black oil
Ex 7, Method B





30
Br
White solid
Ex 7,





Method A





31


embedded image


Solid
Ex 7, Method B





















TABLE 7b





Compound
Mp
ESIMS


13C NMR or

IR(thin


No.
(° C.)
m/z

1H NMR (δ)a


19F NMR (δ)

film) cm−1







26

448
(300 MHz, CDCl3) δ

3337,




([M + H]+)
8.40 (d, J = 2.7 Hz,

2229





1H), 7.71 (m, 2H),





7.54 (m, 2H), 7.41





(dd, J = 8.7, 2.7 Hz,





1H), 7.10 (m, 2H),





6.83 (m, 2H), 6.16 (s,





1H), 5.63 (d, J = 12.7





Hz, 1H), 5.10 (dd, J =





12.7, 1.7 Hz, 1H)


27

429
8.35 (d, J = 2.9 Hz,

19F NMR (376





([M + H]+)
1H), 7.57-7.45 (m,
MHz, CDCl3)





2H), 7.32 (dd, J = 8.8,
δ −78.68 (br), −104.97





2.9 Hz, 1H), 6.87-
(dd, J = 255.68,





6.75 (m, 2H), 6.36 (s,
15.04 Hz), −105.54





1H), 5.62 (d, J = 12.6
(m), −108.44 (d, J =





Hz, 1H), 5.06 (dd, J =
7.52 Hz), −109.49





12.6, 1.6 Hz, 1H), 4.45
(dd, J = 255.68,





(q, J = 7.8 Hz, 2H)
15.04 Hz)


28

492
8.53 (d, J = 2.5 Hz,

19F NMR (376





([M + 1]+)
1H), 8.41 (dd, J = 1.5,
MHz, CDCl3)





0.8 Hz, 1H), 8.00 (dd,
δ −104.97 (d, J = 19.7





J = 8.6, 2.4 Hz, 1H),
Hz), −105.43-−105.73





7.68 (dd, J = 8.6, 2.6
(m), −108.53 (d, J = 9.0





Hz, 1H), 7.63-7.51
Hz), −108.76-−109.77





(m, 2H), 7.16 (d, J =
(m), 61.82 (s)





8.7 Hz, 1H), 6.94-





6.79 (m, 2H), 6.48 (s,





1H), 5.66 (d, J = 12.6





Hz, 1H), 5.09 (dd, J =





12.6, 1.1 Hz, 1H)


29

457
8.50 (d, J = 2.6 Hz,




([M]+)
1H), 8.15-8.06 (m,





1H), 7.75 (dd, J = 8.7,





2.6 Hz, 1H), 7.64 (dd,





J = 8.6, 2.6 Hz, 1H),





7.57 (dd, J = 8.7, 0.8





Hz, 2H), 7.02 (dd, J =





8.7, 0.6 Hz, 1H), 6.89-





6.78 (m, 2H), 6.57





(s, 1H), 5.64 (d, J =





12.5 Hz, 1H), 5.14-





5.00 (m, 1H)


30

409
8.68 (d, J = 2.2 Hz,

19F NMR (376





([M]+)
1H), 7.94 (dd, J = 8.4,
MHz, CDCl3)





2.2 Hz, 1H), 7.53-
δ −105.51 (ddd,





7.45 (m, 1H), 7.41 (d,
J = 30.0, 17.6, 9.5





J = 8.4 Hz, 1H), 6.87-
Hz), −106.02 (dd,





6.77 (m, 2H), 5.93
J = 258.3, 17.4





(s, 1H), 5.65 (d, J =
Hz), −108.03





12.8 Hz, 1H), 5.08
(d, J = 9.5





(dd, J = 12.8, 1.7 Hz,
Hz), −110.56





1H)
(dd, J = 258.2,






30.5 Hz)


31

413
8.56 (s, 1H), 7.78 (dd,




([M + H]+)
J = 8.1, 1.6 Hz, 1H),





7.51 (m, 2H), 6.81 (m,





2H), 6.40 (s, 1H), 5.64





(d, J = 12.6 Hz, 1H),





5.08 (dd, J = 12.6, 1.4





Hz, 1H), 3.46 (q, J =





10.3 Hz, 2H)






aAll 1H NMR data measured in CDCl3 at 400 MHz unless otherwise noted







Example 8. Preparation of 4-((6-(3-amino-2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxypropyl)pyridin-3-yl)oxy)benzonitrile (32)



embedded image



Method A. By Reduction with Zinc Powder:


To a solution of 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-nitropropyl)pyridin-3-yl)oxy)benzonitrile (0.412 g, 0.921 mmol) in acetic acid (3.68 mL) was added zinc powder (0.602 g, 9.21 mmol). The reaction was stirred at rt. After 1 h, LCMS indicated a complete conversion to the desired product. The reaction was filtered through a plug of celite and washed with acetic acid. The filtrate was concentrated to 1 mL by co-evaporating with acetonitrile and was neutralized with sat. aq. NaHCO3. The mixture was extracted with EtOAc. The combined organic phases were dried (MgSO4) and concentrated to give the acetic acid salt of the desired product. The residue was diluted with CH2Cl2, and the organic phase was washed with saturated aqueous NaHCO3, brine, and then dried (MgSO4) and concentrated to give the title compound as a faint yellow foam (296 mg, 77%).


Method B. By Reduction with Tin(II) Chloride:


To a magnetically stirred solution of 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-nitropropyl)pyridin-3-yl)oxy)benzonitrile (0.208 g, 0.465 mmol) (contaminated by 29 mg of nitromethane=0.47 mmol) in ethanol (4.65 mL) was added a solution of anhydrous tin(II) chloride (0.529 g, 2.79 mmol) in HCl (0.848 mL, 27.9 mmol). The reaction mixture was stirred at 60° C. for 4 h. The reaction mixture was poured into ice water and was neutralized with sat. aq. NaHCO3. The mixture was filtered through celite while washing with EtOAc. The filtrate was extracted with EtOAc, and the combined organic phases were washed with brine and water, dried (MgSO4) and concentrated. Purification by silica gel chromatography (0-15% MeOH/DCM) gave the title compound as a faint yellow oil (62 mg, 31.9%).


Method C. By Reduction with Zinc Powder:


Into the flask (500 mL) containing Zn (13.08 g, 200 mmol) in AcOH (40 mL) at 23° C. was added slowly a solution of 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-nitropropyl)pyridin-3-yl)oxy)benzonitrile (8.95 g, 20 mmol) in MeOH (160 mL) at 30-35° C. over 20 min. The mixture was stirred at rt. After completion of reaction, the reaction mixture was diluted with CH2Cl2 (200 mL) and filtered through celite which was rinsed with additional CH2Cl2. The resulting solution was washed with 10% NH4Cl solution. After separation, the aq. layer was extracted with additional CH2Cl2. The combined organic layers were washed with 10% KOH (100 mL) and water (50 mL). The organic layer was concentrated with acetonitrile, and the crude title compound was used in the next step without further purification.


The following compounds 32-37 in Table 8a were made in accordance with the reaction depicted in Scheme 8 and the procedures described in Example 8. Characterization data for compounds 32-37 are shown in Table 8b.




embedded image












TABLE 8a





Compound


Prepared as in


No.
R1
Appearance
Example(s):







32


embedded image


Faint yellow foam
Ex 8, Methods A, B and C





33


embedded image


Oil
Ex 8, Method C





34


embedded image


Light brown oil
Ex 8, Method C





35


embedded image


Light Yellow solid
Ex 8, Method C





36
Br
Colorless
Ex 8,




oil
Method A





37


embedded image


Nearly white solid
Ex 8, Method C





















TABLE 8b





Compound
Mp
ESIMS


13C NMR or

IR(thin


No.
(° C.)
m/z

1H NMR (δ)a


19F NMR (δ)

film) cm−1







32

418
(300 MHz, CDCl3) δ 8.36

3419,




([M + H]+)
(d, J = 2.6 Hz, 1H), 7.67

3076,





(m, 2H), 7.50 (m, 1H), 7.44

2228





(app d, J = 8.6 Hz, 1H),





7.36 (dd, J = 8.6, 2.7 Hz,





1H), 7.05 (m, 2H), 6.76 (m,





2H), 3.84 (dd, J = 13.7, 4.2





Hz, 1H), 3.21 (d, J = 13.5





Hz, 1H), 2.47 (br s, 2H)


33


8.31 (d, J = 2.9 Hz, 1H),





7.50 (td, J = 8.7, 6.6 Hz,





1H), 7.39 (d, J = 8.7 Hz,





1H), 7.29-7.21 (m, 1H),





6.76 (dddd, J = 14.3, 11.5,





8.5, 2.6 Hz, 2H), 6.29 (s,





1H), 4.43 (q, J = 7.9 Hz,





2H), 3.79 (dd, J = 13.6, 4.4





Hz, 1H), 3.22 (d, J = 13.8





Hz, 1H), 1.44-1.07 (m,





2H)


34

460
8.48 (d, J = 2.5 Hz, 1H),




([M − 1])
8.41 (dd, J = 1.6, 0.8 Hz,





1H), 8.02-7.92 (m, 1H),





7.62-7.47 (m, 3H), 7.13





(d, J = 8.6 Hz, 1H), 6.88-





6.72 (m, 2H), 6.35-6.33





(m, 1H), 3.80 (dd, J = 13.7,





4.2 Hz, 1H), 3.26 (d, J =





13.7 Hz, 1H), 0.9-1.6 (br,





2H)


35

457
8.45 (d, J = 2.7 Hz, 1H),




([M]+)
8.09 (dd, J = 2.6, 0.7 Hz,





1H), 7.72 (dd, J = 8.7, 2.6





Hz, 1H), 7.62-7.53 (m,





2H), 7.49 (dd, J = 8.6, 0.7





Hz, 1H), 6.99 (dd, J = 8.7,





0.7 Hz, 1H), 6.79 (dddd, J =





20.5, 11.5, 8.7, 2.4 Hz,





2H), 5.30 (s, 2H), 3.83-





3.63 (m, 1H), 3.28 (d, J =





12.6 Hz, 1H), 1.47 (s, 1H)


36

379
8.62 (dd, J = 7.0, 2.1 Hz,

19F NMR (376





([M]+)
1H), 7.85 (dd, J = 8.4, 2.3
MHz, CDCl3)





Hz, 1H), 7.52-7.41 (m,
δ −106.15 (ddd,





1H), 7.30 (dd, J = 8.4, 0.5
J = 23.2, 15.0, 8.3





Hz, 1H), 6.84-6.68 (m,
Hz), −109.39 (dd,





2H), 3.87 (dd, J = 13.7, 4.7
J = 252.1, 23.3





Hz, 1H), 3.19 (d, J = 13.7
Hz), −110.47 (d,





Hz, 1H), 1.0-1.9 (br, 2H),
J = 8.8 Hz), −110.99





0.8-0.9 (br, 1H)
(dd, J = 252.2, 14.9 Hz)


37

383
8.53-8.49 (m, 1H), 7.69

19F NMR −65.75





([M + H]+)
(dd, J = 8.1, 2.1 Hz, 1H),
(s, 3F), ABX:





7.55-7.41 (m, 2H), 6.82-
X = −106.29





6.70 (m, 2H), 3.80 (dd, J =
(ddd, J = 22.0,





13.6, 4.4 Hz, 1H), 3.43 (q,
15.9, 8.6 Hz, 1F),





J = 10.5 Hz, 2H), 3.23 (dq,
B = −109.27





J = 13.8, 1.1 Hz, 1H)
(JAB = 254.7






Hz, JBX = 21.9






Hz, 1F), −110.61






(d, J = 8.4 Hz,






1F), A = −111.04






(JAB = 254.7,






JAX = 15.9






Hz, 1F)






aAll 1H NMR data measured in CDCl3 at 400 MHz unless otherwise noted







Example 9. Preparation of 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-tetrazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile (38)



embedded image



Method A:


To a magnetically stirred solution of 4-((6-(3-amino-2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxypropyl)pyridin-3-yl)oxy)benzonitrile (0.060 g, 0.144 mmol) in acetic acid (0.288 mL) was added sodium azide (0.019 g, 0.288 mmol) and triethyl orthoformate (0.072 mL, 0.431 mmol). The reaction mixture was stirred at 90° C. for 5 h. The reaction mixture was poured into water and then made basic by addition of sat. aq. NaHCO3 and the mixture extracted with CH2Cl2. The combined organic phases were dried (MgSO4) and concentrated to give the title compound as a faint yellow oil (45 mg, 63.2%).


Method B:


To a magnetically stirred solution of 4-((6-(3-amino-2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxypropyl)pyridin-3-yl)oxy)benzonitrile (20 mmol) in acetonitrile was added AcOH (80 mL), sodium azide (2.6 g, 40 mmol) and triethyl orthoformate (8.89 g, 60 mmol) at room temperature. The reaction mixture was stirred at room temperature for 0.5 h and heated to 35-40° C. for 20 hours. After completion of reaction by HPLC, the reaction mixture was concentrated with additional acetonitrile and MeOH. The resulting residual oil was dissolved in MeOH (40 mL), and then the solution was charged slowly to water (300 mL) at room temperature. The precipitated solid was stirred for 2-3 h at room temperature. The suspension was filtered and washed with water. The cake was dried under vacuum at room temperature to give the title compound (9.02 g, 94%).


The following compounds 38-43 in Table 9a were made in accordance with the reaction depicted in Scheme 9 and the procedures described in Example 9. Characterization data for compounds 38-43 are shown in Table 9b.




embedded image












TABLE 9a





Compound


Prepared as in


No.
R1
Appearance
Example(s):







38


embedded image


off-white solid
Ex 9, Methods A and B





39


embedded image


Foam
Ex 9, Method B





40


embedded image


Pink colored foam
Ex 9, Method B





41


embedded image


Dark yellow solid
Ex 9, Method B





42
Br
Light brown
Ex 9,




thick oil
Method A





43


embedded image


Slightly yellowed glass
Ex 9, Method B





















TABLE 9b





Compound
Mp
ESIMS


13C NMR or

IR(thin


No.
(° C.)
m/z

1H NMR (δ)a


19F NMR (δ)

film) cm−1



















38

469
(300 MHz, CDCl3) δ

19F NMR (376 MHz,





([M − H])
8.74 (s, 1H), 8.26 (d, J =
CDCl3) δ −104.05





2.7 Hz, 1H), 7.71 (m,
(m), −105.67 (dd, J =





2H), 7.62 (d, J = 8.7 Hz,
263.9, 20.1 Hz), −107.32





1H), 7.43 (m, 2H), 7.19
(dd, J = 264.1,





(s, 1H), 7.12 (m, 2H),
34.3 Hz), −107.83





6.76 (m, 2H), 5.44 (d, J =
(d, J = 9.6 Hz)





14.4 Hz, 1H), 5.23 (dd,





J = 14.4, 1.5 Hz, 1H)


39

452
8.75 (s, 1H), 8.27 (d, J =

19F NMR (376 MHz,





([M + H]+)
2.9 Hz, 1H), 7.57 (d, J =
CDCl3) δ −73.68





8.8 Hz, 1H), 7.36-7.28
(m), −103.79 (dd,





(m, 2H), 7.26 (s, 1H),
J = 263.2, 41.46





6.76 (ddd, J = 12.0, 8.5,
Hz), −104.93 (m),





2.6 Hz, 1H), 6.71-6.62
108.00 (d, J = 11.28





(m, 1H), 5.57 (dd, J =
Hz), −110.45 (dd, J =





14.3, 0.8 Hz, 1H), 5.12
263.2, 41.46 Hz)





(dd, J = 14.3, 1.5 Hz,





1H), 4.44 (q, J = 7.8 Hz,





2H)


40

515
8.79 (s, 1H), 8.48 (d, J =




([M + H]+)
2.4 Hz, 1H), 8.41 (dd, J =





1.6, 0.8 Hz, 1H), 8.01





(dd, J = 8.6, 2.4 Hz,





1H), 7.68 (dt, J = 18.4,





5.5 Hz, 2H), 7.37 (td, J =





8.9, 6.5 Hz, 2H), 7.17





(d, J = 8.6 Hz, 1H), 6.82-





6.72 (m, 1H), 6.72-





6.62 (m, 1H), 5.64 (d, J =





14.3 Hz, 1H), 5.13 (d,





J = 14.4 Hz, 1H)


41
61-63
480
8.76 (s, 1H), 8.53-8.39




([M]+)
(m, 1H), 8.09 (dd, J =





2.7, 0.7 Hz, 1H), 7.75





(dd, J = 8.7, 2.6 Hz,





1H), 7.71-7.53 (m,





2H), 7.35 (td, J = 8.9,





6.4 Hz, 1H), 7.02 (dd, J =





8.7, 0.7 Hz, 1H), 6.77





(ddd, J = 12.0, 8.5, 2.6





Hz, 1H), 6.72-6.66 (m,





1H), 5.68-5.58 (m,





1H), 5.14-5.07 (m,





1H), 2.10 (s, 1H)


42

  432.11
8.76 (s, 1H), 8.63 (d, J =

19F NMR (376





([M]+)
1.4 Hz, 1H), 7.95 (dd, J =
MHz, CDCl3)





8.4, 2.2 Hz, 1H), 7.46
δ −103.52-−103.97





(d, J = 8.4 Hz, 1H), 7.34-
(m), −103.96-−104.40





7.23 (m, 1H), 6.93 (s,
(m), −107.62 (d, J =





1H), 6.81-6.72 (m,
9.7 Hz), −112.16





1H), 6.72-6.62 (m,
(dd, J = 263.2,





1H), 5.61 (d, J = 14.3
43.0 Hz)





Hz, 1H), 5.12 (d, J =





14.8 Hz, 1H)


43

436
8.76 (s, 1H), 8.49 (d, J =

19F NMR (376 MHz,





([M + H]+)
2.0 Hz, 1H), 7.79 (dd, J =
CDCl3) δ −65.61 (s,





8.1, 2.1 Hz, 1H), 7.60
3F), ABX: X= −103.93





(d, J = 8.1 Hz, 1H),
(ddd, JAX = 41.9 Hz,





7.37-7.28 (m, 2H), 6.76
JAB = 15.4, 9.8 Hz,





(ddd, J = 12.1, 8.5, 2.6
1F), B = −104.75





Hz, 1H), 6.65 (dddd, J =
(JAB = 262.9 Hz,





8.7, 7.5, 2.6, 0.9 Hz,
JBX = 15.5 Hz,





1H), 5.59 (dd, J = 14.3,
1F), −107.91 (d, J =





0.9 Hz, 1H), 5.13 (dd, J =
9.7 Hz, 1F),





14.1, 1.4 Hz, 1H),
A = −111.65





3.45 (q, J = 10.3 Hz,
(JAB = 262.9 Hz,





2H)
JAX = 41.6 Hz, 1F)






aAll 1H NMR data measured in CDCl3 at 400 MHz unless otherwise noted






Claims
  • 1. A method of making compounds of Formula III, including the step of:
  • 2. The method of claim 1, wherein the preformed organometallic reagent is formed by a metal halogen exchange reaction of 1-bromo-2,4-difluorobenzene with one of magnesium, n-butyllithium, and isopropylmagnesium chloride.
  • 3. The method of claim 1, wherein the step of contacting compounds of Formula Ha with the preformed organometallic reagent further includes an aprotic solvent.
  • 4. The method of claim 3, wherein the aprotic solvent is one of diethyl ether and tetrahydrofuran.
  • 5. The method of claim 1 wherein the step of contacting compounds of Formula IIa with the preformed organometallic reagent is carried out at about 0° C.
  • 6. The method of claim 1, further comprising the step of: contacting compounds of Formula II with an amine, a Lewis acid, and a solvent
  • 7. The method of claim 6, wherein the amine is selected from N,O-dimethylhydroxylamine, dimethylamine, diethylamine and morpholine.
  • 8. The method of claim 6, wherein the Lewis acid is dimethylaluminum chloride.
  • 9. The method of claim 6, wherein the solvent is dichloromethane.
  • 10. The method of claim 6, wherein the step of contacting compounds of Formula II with the amine, the Lewis acid, and the solvent is carried out in such a manner as to maintain a temperature below about 15° C.
  • 11. The method of claim 6, further comprising the step of: contacting compounds of the Formula I with ethyl 2-bromo-2,2-difluoroacetate and a metal
  • 12. The method of claim 11, wherein the metal is copper.
  • 13. The method of claim 11, wherein the step of contacting I with ethyl 2-bromo-2,2-difluoroacetate and a metal further includes a solvent.
  • 14. The method of claim 13, wherein the solvent is selected from dimethyl sulfoxide, dimethylformamide, and mixtures thereof.
  • 15. The method of claim 11, further comprising the step of: Contacting 6-bromopyridin-3-ol with one of 5-chloro-2-fluoropyridine and 2-fluoro-5-(trifluoromethyl)pyridine.
  • 16. The method of claim 15, wherein the step of contacting 6-bromopyridin-3-ol with one of 5-chloro-2-fluoropyridine and 2-fluoro-5-(trifluoromethyl)pyridine further includes a base.
  • 17. The method of claim 16, wherein the base is one of cesium carbonate and potassium carbonate.
  • 18. The method of claim 15, wherein the step of contacting 6-bromopyridin-3-ol with one of 5-chloro-2-fluoropyridine and 2-fluoro-5-(trifluoromethyl)pyridine further includes a solvent.
  • 19. The method of claim 18, wherein the solvent is one of dimethyl sulfoxide and dimethylformamide.
  • 20. The method of claim 15 wherein the step of contacting 6-bromopyridin-3-ol with one of 5-chloro-2-fluoropyridine and 2-fluoro-5-(trifluoromethyl)pyridine is carried out between 65° C. and 100° C.
  • 21. The method of claim 11, further comprising the step of: Contacting 6-bromopyridin-3-ol with 2,2,2-trifluoroethyl trifluoromethanesulfonate.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is the U.S. National Stage, pursuant to 35 U.S.C. § 371, of International Application No. PCT/US2015/021527, filed Mar. 19, 2015, which claims the benefit of U.S. Provisional Patent Application Ser. No. 61/955,680 filed Mar. 19, 2014, the entire disclosures of which are incorporated by reference herein.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2015/021527 3/19/2015 WO 00
Publishing Document Publishing Date Country Kind
WO2015/143192 9/24/2015 WO A
US Referenced Citations (43)
Number Name Date Kind
4426531 Bison et al. Jan 1984 A
8236962 Hoekstra et al. Aug 2012 B2
8748461 Hoekstra et al. Jun 2014 B2
8754227 Hoekstra et al. Jun 2014 B2
8796001 Hoekstra et al. Aug 2014 B2
8809378 Hoekstra et al. Aug 2014 B2
8883785 Dominguez Nov 2014 B2
8883797 Hoekstra et al. Nov 2014 B2
8901121 Hoekstra et al. Dec 2014 B2
8940735 Hoekstra et al. Jan 2015 B2
9220265 Hoekstra et al. Dec 2015 B2
9221791 Hoekstra et al. Dec 2015 B2
9309273 Hoekstra et al. Apr 2016 B2
9414596 Hoekstra et al. Aug 2016 B2
9447073 Hoekstra et al. Sep 2016 B2
9556143 Hoekstra et al. Jan 2017 B2
9663488 Hoekstra et al. May 2017 B2
9688671 Hoekstra et al. Jun 2017 B2
20090318436 Albrecht Dec 2009 A1
20110306644 Hoekstra Dec 2011 A1
20120329788 Hoekstra et al. Dec 2012 A1
20120329802 Hoekstra et al. Dec 2012 A1
20130005719 Hoekstra et al. Jan 2013 A1
20130005729 Hoekstra et al. Jan 2013 A1
20130005752 Hoekstra et al. Jan 2013 A1
20130005776 Hoekstra et al. Jan 2013 A1
20130012503 Hoekstra et al. Jan 2013 A1
20140288107 Hoekstra et al. Sep 2014 A1
20140350003 Hoekstra et al. Nov 2014 A1
20150004666 Hoekstra et al. Jan 2015 A1
20150024938 Hoekstra et al. Jan 2015 A1
20150099750 Hoekstra et al. Apr 2015 A1
20160214959 Hoekstra et al. Jul 2016 A1
20170081285 Hoekstra et al. Mar 2017 A1
20170081309 Hoekstra et al. Mar 2017 A1
20170081310 Hoekstra et al. Mar 2017 A1
20170081316 Hoekstra et al. Mar 2017 A1
20170088539 Hoekstra et al. Mar 2017 A1
20170088540 Hoekstra et al. Mar 2017 A1
20170096410 Hoekstra et al. Apr 2017 A1
20170121307 Hoekstra May 2017 A1
20170144990 Hoekstra May 2017 A1
20170144991 Hoekstra May 2017 A1
Foreign Referenced Citations (32)
Number Date Country
1126722 Jul 1996 CN
1334811 Feb 2002 CN
102811620 Dec 2012 CN
2000-344744 Dec 2000 JP
WO 0037459 Jun 2000 WO
WO 2014-193974 Dec 2004 WO
WO 2009020323 Feb 2009 WO
WO 2010146113 Dec 2010 WO
WO 2010147302 Dec 2010 WO
WO 2011133875 Oct 2011 WO
WO 2012177608 Dec 2012 WO
WO 2012177635 Dec 2012 WO
WO 2012177725 Dec 2012 WO
WO 2012177728 Dec 2012 WO
WO2012177603 Dec 2012 WO
WO 2013109998 Jul 2013 WO
WO 2013110002 Jul 2013 WO
WO2014043376 Mar 2014 WO
WO2014165861 Oct 2014 WO
WO 2015143184 Sep 2015 WO
WO 2015143192 Sep 2015 WO
WO2015143154 Sep 2015 WO
WO2015143162 Sep 2015 WO
WO2016187201 Nov 2016 WO
WO2017049080 Mar 2017 WO
WO2017049096 Mar 2017 WO
WO2017049196 Mar 2017 WO
WO 2017087592 May 2017 WO
WO 2017087597 May 2017 WO
WO 2017087619 May 2017 WO
WO 2017087643 May 2017 WO
WO 2017117393 Jul 2017 WO
Non-Patent Literature Citations (30)
Entry
Biju; Synthetic Communications, 2008, 38, 1940-1945.
Eto; Chemical and Pharmaceutical Bulletin, 2000, 48, 982-990.
Shimizu; Tetrahedron Letters, 1997, 38, 2685-2688.
International Search Report and Written Opinion dated Jun. 25, 2015 for Application No. PCT/US2015/021436.
International Search Report and Written Opinion dated Jun. 29, 2015 for Application No. PCT/US2015/021445.
International Search Report and Written Opinion dated Jun. 26, 2015 for Application No. PCT/US2015/021519.
International Search Report and Written Opinion dated Jun. 29, 2015 for Application No. PCT/US2015/021527.
International Search Report and Written Opinion dated Jul. 14, 2015 for Application No. PCT/US2015/021464.
International Search Report and Written Opinion dated Jul. 14, 2015 for Application No. PCT/US2015/021476.
International Search Report and Written Opinion dated Jul. 10, 2015 for Application No. PCT/US2015/021484.
International Search Report and Written Opinion dated Jun. 24, 2015 for Application No. PCT/US2015/021491.
International Search Report and Written Opinion dated Jun. 26, 2015 for Application No. PCT/US2015/021504.
International Search Report and Written Opinion dated Jun. 24, 2015 for Application No. PCT/US2015/021511.
Partial Supplementary European Search Report and Search Opinion dated Jul. 13, 2017 for EP Application No. 15765715.6.
Partial Supplementary European Search Report and Search Opinion dated Aug. 3, 2017 for EP Application No. 15764600.1.
Extended European Search Report and Search Opinion dated Aug. 1, 2017 for EP Application No. 15764570.6.
Extended European Search Report and Search Opinion dated Aug. 23, 2017 for EP Application No. 15765402.1.
Partial Supplementary European Search Report and Search Opinion dated Jul. 19, 2017 for EP Application No. 15764259.6.
Extended European Search Report and Search Opinion dated Jul. 3, 2017 for EP Application No. 15764654.8.
Extended European Search Report and Search Opinion dated Aug. 1, 2017 for EP Application No. 15764368.5.
Extended European Search Report and Search Opinion dated Jul. 21, 2017 for EP Application No. 15764743.9.
Extended European Search Report and Search Opinion dated Jul. 21, 2017 for EP Application No. 15764771.0.
Extended European Search Report and Search Opinion dated Jul. 13, 2017 for EP Application No. 15765307.2.
International Search Report and Written Opinion dated Feb. 3, 2017 for Application No. PCT/U52016/032877.
Kolb et al., Catalytic Asymmetric Dihydroxylation. Chemical Reviews 1994;94(8):2483-2547. doi: 10.1021/cr00032a009.
Uemura et al., Enantioselective Cyanosilylation of Ketones with Amino Acid/BINAP/Ruthenium(II)-Lithium Phenoxide Catalyst System. Advanced Synthesis & Catalysis. Jul. 2012;354(10):2023-30. doi: 10.1002/adsc.201200027.
Clemencon et al., Tandem Multicomponent/Click Reactions: Synthesis of Functionalized Oxazoles and Tetrazoles from Acyl Cyanides. Tetrahedron. 2007;63:8665-9.
Demko et al., A Click Chemistry Approach to Tetrazoles by Huisgen 1,3-Dipolar Cycloaddition: Synthesis of 5-Sulfonyl Tetrazoles from Azides and Sulfonyl Cyanides. Angew. Chem. Int. Ed. Dec. 2002;41(12):2110-3.
Otsuki et al., Chemical tagging of a drug target using 5-sulfonyl tetrazole. Bioorg Med Chem Lett. Mar. 15, 2013;23(6):1608-11. doi:10.1016/j.bmcl.2013.01.092. Epub Jan. 30, 2013.
Putis et al. Tetrazole-containing derivatives of 4-amino-3-phenylbutanoic acid. Arkivoc. Dec. 2009; 2009(4): 64-8. doi: http://dx.doi.org/10.3998/ark.5550190.0010.406.
Related Publications (1)
Number Date Country
20170158667 A1 Jun 2017 US
Provisional Applications (1)
Number Date Country
61955680 Mar 2014 US